Arvin Yang
2022
Compensation breakdown
| Non-Equity Incentive Plan | $245,450 |
|---|---|
| Option Awards | $582,726 |
| Salary | $527,850 |
| Stock Awards | $177,931 |
| Other | $7,000 |
| Total | $1,540,957 |
Yang received $582.7K in option awards, accounting for 38% of the total pay in 2022.
Yang also received $245.5K in non-equity incentive plan, $527.9K in salary, $177.9K in stock awards and $7K in other compensation.
Rankings
In 2022, Arvin Yang's compensation ranked 2,168th out of 5,717 executives tracked by ExecPay. In other words, Yang earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,168 out of 5,717 | 62nd |
Division Manufacturing | 1,166 out of 3,111 | 63rd |
Major group Chemicals And Allied Products | 500 out of 1,410 | 65th |
Industry group Drugs | 460 out of 1,311 | 65th |
Industry Pharmaceutical Preparations | 334 out of 957 | 65th |
Pay ratio
| Arvin Yang's Pay | $1,540,957 |
|---|---|
| Median Employee's Pay | $243,051 |
| Pay Ratio | 6to 1 |
In 2022, the annual total compensation of Arvin Yang was $1,540,957.
The annual total compensation of the median employee at Mersana Therapeutics was $243,051.
The ratio of Arvin Yang's pay to the pay of median employee was therefore 6 to one.
Yang's colleagues
We found four more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2022.
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021